Elisabethinen Hospital Clinical Trials
Sponsors / Elisabethinen Hospital
Elisabethinen Hospital is listed as the lead sponsor on 11 clinical trials registered with ClinicalTrials.gov. 2 trials are actively recruiting participants, 1 remain active without open enrollment, and 1 have concluded. 3 of these trials ended early via termination or withdrawal. The most common reasons cited for termination include slow or insufficient recruitment. The cumulative planned enrollment figure across all listed trials is 1,595 participants. All figures are drawn directly from ClinicalTrials.gov and updated as sponsors submit revisions.
11
Total Trials
2
Recruiting
1
Other Active
1
Completed
3
Terminated / Withdrawn
1,595
Total Enrollment
Termination reasons: Recruitment100%
Recent Terminations
- Cardiac Resynchronization Therapy"The feasibility (recruitment) of the high number of patients (402 patients with HFrEF or HFmrEF) was impossible due to the rapid increase in SGLT2 inhibitors in patients with heart failure."
- Antibody-mediated Rejection"Slow enrollment"
- Hematologic Malignancies"reduced recruitment rate due to non infectious, but competitive trials at our institution"
Active Trials (1 total)
- NCT07170761
- NCT05942833
- Circulating Tumor Cell PHASE3NCT06391892
Top Conditions
Antibody-mediated rejection (1) Ckd-mbd - chronic kidney disease mineral and bone disorder (1) Cardiac resynchronization therapy (1) Circulating tumor cell (1) Cryotherapy (1) Diverticulitis of sigmoid (1) Hematologic malignancies (1) Hiatal hernia (1) Inspiratory muscle training (1) Metastatic cancer (1)